Physician

Mohammad T Ansari, M.D.

According to 2025 Medicare claims, Mohammad Ansari, M.D. (NPI: 1578528428) practices cardiology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is CITRUS CARDIOLOGY CONSULTANTS, PLLC (NPI: 1669405379; TIN: 59-2123944) and primary practice location at 34461-9223. Ansari is affiliated with the Health First Physicians ACO (ACO ID: A5451) and Pathways Accountable Care, LLC d/b/a Pathways Health Partners (ACO ID: D0048), participating under both the MSSP and REACH models.

Ansari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,429 traditional Medicare patients, billed 5,803 HCPCS/CPT codes, and received $420,843 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,662 prescription claims across 830 beneficiaries totaling $1,379,471 in drug costs, led by Eliquis (Apixaban). DME data shows 22 claims. Open Payments data shows 27 records totaling $3,536. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $574,388 to $420,843. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $342,481 to $1,379,471. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $20,765 to $8,548.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,844	7,754	$574,388
2016	2,349	7,642	$473,103
2017	2,597	8,519	$528,488
2018	2,805	8,641	$495,791
2019	3,019	8,914	$473,751
2020	2,387	7,847	$451,314
2021	1,918	6,194	$333,532
2022	2,101	6,883	$374,024
2023	1,933	6,337	$363,785
2024	1,429	5,803	$420,843

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	563	3,311	$342,481
2016	586	3,657	$447,512
2017	653	3,771	$458,359
2018	737	4,403	$660,986
2019	815	4,941	$888,114
2020	797	5,303	$1,009,141
2021	773	5,266	$1,062,049
2022	771	5,075	$1,112,145
2023	774	5,137	$1,244,302
2024	830	5,662	$1,379,471

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	13	$20,554
2019	N/R	22	$48,874
2020	N/R	23	$475
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	22	$2,329

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	364	369	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	697	1,353	$94
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	198	217	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	135	149	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	475	640	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	441	28,717	$530,156
Xarelto	Rivaroxaban	307	22,120	$398,700
Entresto	Sacubitril/Valsartan	138	8,284	$160,475
Repatha Sureclick	Evolocumab	50	2,942	$51,503
Farxiga	Dapagliflozin Propanediol	38	2,435	$43,574

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0471	Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	11	$1,966
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	11	$364

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$756	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$2,780	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohammad T. Ansari, M.D.?

Tedicare shows public-source Medicare data for Mohammad T. Ansari, M.D. (NPI 1578528428), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammad T. Ansari, M.D. have ACO affiliation data?

Mohammad T. Ansari, M.D. is shown with ACO affiliation data for Health First Physicians ACO (MSSP, ACO ID A5451) and Pathways Accountable Care, LLC d/b/a Pathways Health Partners (REACH, ACO ID D0048).

What billing organization is linked to Mohammad T. Ansari, M.D.?

Mohammad T. Ansari, M.D. is linked to CITRUS CARDIOLOGY CONSULTANTS, PLLC (billing NPI 1669405379) in the available physician profile data.

Does Mohammad T. Ansari, M.D. have Open Payments data?

Mohammad T. Ansari, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.